血液造血干细胞移植患者的疫苗接种覆盖率
Angeles Bouzas-Rodríguez1,2, Germán Molina-Romera3, Juan Manuel Vázquez-Lago1,4
1Department of Preventive Medicine and Public Health, University of Santiago de Compostela, 15786 Santiago de Compostela, Spain.
Vaccines
|April 23, 2025
概括
血造后干细胞移植 (HSCT) 接种疫苗的覆盖率很低,只有41.12%的患者完成了计划. 改善的疫苗接种计划和意识对于这种高风险人群至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 公共卫生 公共卫生
背景情况:
- 造血干细胞移植 (HSCT) 会导致严重的免疫抑制,增加感染风险.
- 再接种疫苗对于降低HSCT接受者的发病率和死亡率至关重要.
- 评估移植后的疫苗接种覆盖率对于优化患者护理至关重要.
研究的目的:
- 在一个专门的中心评估HSCT患者的移植后疫苗接种覆盖率.
- 为了确定影响疫苗接种遵守的因素.
- 为改进免疫策略的开发提供信息.
主要方法:
- 138名HSCT患者 (2018年1月至2021年5月) 的横截面,回顾性研究.
- 根据西班牙卫生部指导方针评估疫苗接种覆盖率.
- 竞争风险生存分析用于解释死亡率.
主要成果:
- 只有41.12%的患者在19个月内完全遵守疫苗接种计划.
- 只有1.87%的患者实现了时间合规.
- 没有发现性别与疫苗接种状况或竞争风险之间的显著关联.
结论:
- 在HSCT后的疫苗接种覆盖率仍然低于最佳水平.
- 需要加强疫苗接种计划和多学科支持.
- 提高公众和专业人士的意识对于这个高风险群体的及时免疫接种至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Tissue Transplantation
271
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
271
Hematopoiesis
4.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
4.9K


